Seller record · Research vendor

Prime Peptides

By Peptide Alliance, Editorial publisherRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S1, prescriber requirement: No clinician evaluation is claimed anywhere on the site, and every page footer sells the products for research purposes only. 2 more criteria also fail; see the table below.

At a glance

Prime PeptidesResearch vendor

5/8criteria passed

Price: Printed on its own pages before sign-up
Sells: research peptides including semaglutide, tirzepatide and retatrutide, and 4 more
FDA letters: 1 on file

Visit Prime Peptides See all eight dispositions

Research vendor. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A research peptide seller trading from a Santa Barbara address, offering vials of GLP-1 analogues and repair peptides. Its questions page links a certificate page that returns an error, while its testing page carries the certificates it describes.

Operating entity No legal entity name is printed in the footer, the contact page, the terms of service or the privacy policy.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	FAIL	Prime Peptides' terms of service page
S2	Prescription gating	FAIL	Prime Peptides' checkout
S3	Pharmacy identification	FAIL	Prime Peptides' about page
S4	Compounding disclosure	PASS	Prime Peptides' terms of service page
S5	Analytical documentation	PASS	Prime Peptides' semaglutide march test vanguard document
S6	Business address	PASS	Prime Peptides' contact page
S7	Price disclosure	PASS	Prime Peptides' shop page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1FAILNo clinician evaluation is claimed anywhere on the site, and every page footer sells the products for research purposes only.Source: Prime Peptides' terms of service page.

S2FAILA checkout collects billing details with no eligibility question, starting from the semaglutide page at 70.00 dollars.Source: Prime Peptides' checkout.

S3FAILThe word pharmacy appears nowhere on the site, and the seller describes itself as a supplier of research compounds.Source: Prime Peptides' about page.

S4PASSThe seller offers no compounded drug, and a footer notice on every page states that the products are for research purposes only and not for human consumption.Source: Prime Peptides' terms of service page.

S5PASSThe testing page links public certificates with no login, among them one from Vanguard Laboratory of Olympia reporting 99.02 percent purity on semaglutide lot 2122026SM by HPLC with an endotoxin pass. The questions page points instead at a certificate page that returns an error.Source: Prime Peptides' semaglutide march test vanguard document.

S6PASSThe contact page prints a street address with a suite number on East De La Guerra Street in Santa Barbara, California.Source: Prime Peptides' contact page.

S7PASSThe shop prints 70.00 dollars for semaglutide and 55.00 dollars for BPC-157 with no account required, and the cart carries the same semaglutide figure.Source: Prime Peptides' shop page.

S8PASSFDA warning letter 695156, December 2024, names Prime Vitality, Inc. doing business as Prime Peptides and alleges its peptide products are unapproved new drugs. No FDA action has halted the business, and the seller still trades.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: research peptides including semaglutide, tirzepatide and retatrutide, BPC-157, tesamorelin, MOTS-c, GLP-2.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells tesamorelin Who sells BPC-157 Who sells MOTS-c Who sells retatrutide

Enforcement documents on file: 1 warning letter

FDA warning letter 695156, issued December 2024, to Prime Vitality, Inc. dba Prime PeptidesThe peptide products offered from Prime Peptides' website are unapproved new drugs intended for human use, despite research-only labeling.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Visit Prime Peptides

535 sellers pass S1, prescriber requirement

See all 535 on the S1 criterion page — 527 more than shown here.

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.